JD Health International Inc.

Symbol: JDHIY

PNK

3.42

USD

Market price today

  • 24.5068

    P/E Ratio

  • 0.1671

    PEG Ratio

  • 11.66B

    MRK Cap

  • 0.00%

    DIV Yield

JD Health International Inc. (JDHIY) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.22%

Operating Profit Margin

0.01%

Net Profit Margin

0.04%

Return on Assets

0.05%

Return on Equity

0.07%

Return on Capital Employed

0.02%

Company general description and statistics

Sector: Healthcare
Industry: Medical Care Facilities
CEO:Mr. Enlin Jin
Full-time employees:2751
City:Beijing
Address:Jingdong Headquarters
IPO:2022-04-04
CIK:

JD Health International Inc., an investment holding company, operates an online healthcare platform in the People's Republic of China. It offers pharmaceutical and healthcare products, including OTC drugs, prescription drugs, and medical devices and supplies, as well as health supplements and tonics through direct selling and an online retail pharmacy network. The company also provides online healthcare services, online consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services; health management and intelligent healthcare solutions, as well as technical and advertising services. In addition, it offers access to medical checkups, medical aesthetics, vaccination appointments, dental care services, and nucleic acid testing tests. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.

General Outlook

When we look at how much money they make before expenses, they keep 0.222% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.012%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.040%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.050% return, is a testament to JD Health International Inc.'s adeptness in optimizing resource deployment. JD Health International Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.066%. Furthermore, the proficiency of JD Health International Inc. in capital utilization is underscored by a remarkable 0.019% return on capital employed.

Stock Prices

JD Health International Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $3.85, while its low point bottomed out at $3.85. This variance in figures offers investors a lucid insight into the roller-coaster ride that is JD Health International Inc.'s stock market.

Liquidity Ratios

Analyzing JDHIY liquidity ratios reveals its financial health of the firm. The current ratio of 328.08% gauges short-term asset coverage for liabilities. The quick ratio (289.29%) assesses immediate liquidity, while the cash ratio (103.20%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio328.08%
Quick Ratio289.29%
Cash Ratio103.20%

Profitability Ratios

JDHIY profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 5.12% underscores its earnings before tax deductions. The effective tax rate stands at 20.09%, revealing its tax efficiency. The net income per EBT, 78.15%, and the EBT per EBIT, 434.42%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 1.18%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin5.12%
Effective Tax Rate20.09%
Net Income per EBT78.15%
EBT per EBIT434.42%
EBIT per Revenue1.18%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 3.28, it details the span from stock purchase to revenue. The 3 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 8401.45% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding289
Days of Inventory Outstanding33
Operating Cycle36.88
Days of Payables Outstanding56
Cash Conversion Cycle-20
Receivables Turnover84.01
Payables Turnover6.47
Inventory Turnover11.22
Fixed Asset Turnover108.30
Asset Turnover1.25

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 2.16, and free cash flow per share, 2.13, depict cash generation on a per-share basis. The cash per share value, 12.93, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.09, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share2.16
Free Cash Flow per Share2.13
Cash per Share12.93
Operating Cash Flow Sales Ratio0.09
Free Cash Flow to Operating Cash Flow Ratio0.99
Cash Flow Coverage Ratio31.46
Short Term Coverage Ratio69.09
Capital Expenditure Coverage Ratio69.03
Dividend Paid and Capex Coverage Ratio69.03

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 0.34%, highlights its total liabilities relative to assets. The long-term debt to capitalization, 0.24%, and total debt to capitalization, 0.44%, ratios shed light on its capital structure. An interest coverage of 99.77 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio0.34%
Long Term Debt to Capitalization0.24%
Total Debt to Capitalization0.44%
Interest Coverage99.77
Cash Flow to Debt Ratio31.46
Company Equity Multiplier1.30

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 17.14, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.69, reflects the portion of profit attributed to each share. The book value per share, 15.80, represents the net asset value distributed per share, while the tangible book value per share, 15.11, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share17.14
Net Income Per Share0.69
Book Value Per Share15.80
Tangible Book Value Per Share15.11
Shareholders Equity Per Share15.80
Interest Debt Per Share0.07
Capex Per Share-0.02

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 52.32%, indicates top-line expansion, while the gross profit growth, 37.43%, reveals profitability trends. EBIT growth, 193.70%, and operating income growth, 193.70%, offer insights into operational profitability progression. The net income growth, 135.41%, showcases bottom-line expansion, and the EPS growth, 134.29%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth52.32%
Gross Profit Growth37.43%
EBIT Growth193.70%
Operating Income Growth193.70%
Net Income Growth135.41%
EPS Growth134.29%
EPS Diluted Growth134.29%
Weighted Average Shares Growth0.39%
Weighted Average Shares Diluted Growth1.60%
Operating Cash Flow Growth72.13%
Free Cash Flow Growth24.71%
10-Year Revenue Growth per Share747.08%
5-Year Revenue Growth per Share747.08%
3-Year Revenue Growth per Share333.86%
10-Year Operating CF Growth per Share16356.52%
5-Year Operating CF Growth per Share16356.52%
3-Year Operating CF Growth per Share1351.50%
10-Year Net Income Growth per Share114.28%
5-Year Net Income Growth per Share114.28%
3-Year Net Income Growth per Share139.37%
10-Year Shareholders Equity Growth per Share6701.84%
5-Year Shareholders Equity Growth per Share6701.84%
3-Year Shareholders Equity Growth per Share9918.64%
Receivables Growth309.78%
Inventory Growth97.16%
Asset Growth27.66%
Book Value per Share Growth11.93%
Debt Growth-0.92%
R&D Expense Growth19.52%
SGA Expenses Growth-43.30%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 94,908,808,988.36, captures the company's total value, considering both debt and equity. Income quality, 2.15, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.04, gauges operational efficiency, while the research and development to revenue, 2.29%, highlights investment in innovation. The ratio of intangibles to total assets, 3.39%, indicates the value of non-physical assets, and capex to operating cash flow, -1.51%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value94,908,808,988.36
Income Quality2.15
Sales General and Administrative to Revenue0.04
Research and Development to Revenue2.29%
Intangibles to Total Assets3.39%
Capex to Operating Cash Flow-1.51%
Capex to Revenue-0.13%
Capex to Depreciation-30.48%
Stock-Based Compensation to Revenue3.45%
Graham Number15.61
Return on Tangible Assets3.45%
Graham Net Net9.55
Working Capital33,264,892,000
Tangible Asset Value47,188,064,000
Net Current Asset Value32,931,855,000
Average Receivables1,841,497,000
Average Payables10,093,239,500
Average Inventory5,783,894,500
Days Sales Outstanding7
Days Payables Outstanding85
Days of Inventory On Hand49
ROIC1.02%
ROE0.04%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 1.60, and the price to book ratio, 1.60, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.98, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 11.58, and price to operating cash flows, 11.41, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio1.60
Price to Book Ratio1.60
Price to Sales Ratio0.98
Price Cash Flow Ratio11.41
Price Earnings to Growth Ratio0.17
Enterprise Value Multiple74.52
Price Fair Value1.60
Price to Operating Cash Flow Ratio11.41
Price to Free Cash Flows Ratio11.58
Price to Tangible Book Ratio2.22
Enterprise Value to Sales1.77
Enterprise Value Over EBITDA110.58
EV to Operating Cash Flow20.65
Earnings Yield1.95%
Free Cash Flow Yield4.12%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of JD Health International Inc. (JDHIY) on the PNK in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 24.507 in 2024.

What is the ticker symbol of JD Health International Inc. stock?

The ticker symbol of JD Health International Inc. stock is JDHIY.

What is company IPO date?

IPO date of JD Health International Inc. is 2022-04-04.

What is company current share price?

Current share price is 3.420 USD.

What is stock market cap today?

The market cap of stock today is 11656466921.000.

What is PEG ratio in 2024?

The current 0.167 is 0.167 in 2024.

What is the number of employees in 2024?

In 2024 the company has 2751.